Cargando…
Double bronchodilation in chronic obstructive pulmonary disease: a crude analysis from a systematic review
OBJECTIVE: The combination of a long-acting muscarinic antagonist (LAMA) and a long-acting β(2)-agonist (LABA) in a single inhaler is a viable treatment option for patients with chronic obstructive pulmonary disease (COPD). Here, we systematically review the current knowledge on double bronchodilati...
Autores principales: | Lopez-Campos, Jose Luis, Calero-Acuña, Carmen, Márquez-Martín, Eduardo, Quintana Gallego, Esther, Carrasco-Hernández, Laura, Abad Arranz, Maria, Ortega Ruiz, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491571/ https://www.ncbi.nlm.nih.gov/pubmed/28694697 http://dx.doi.org/10.2147/COPD.S132962 |
Ejemplares similares
-
Triple therapy for COPD: a crude analysis from a systematic review of
the evidence
por: Lopez-Campos, Jose Luis, et al.
Publicado: (2019) -
Predictors of Single Bronchodilation Treatment Response for COPD: An Observational Study with the Trace Database Cohort
por: Hernández, Laura Carrasco, et al.
Publicado: (2021) -
Specific networks of plasma acute phase reactants are associated with the severity of chronic obstructive pulmonary disease: a case-control study
por: Arellano-Orden, Elena, et al.
Publicado: (2017) -
Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine
por: Carrasco-Hernández, Laura, et al.
Publicado: (2021) -
Understanding of COPD among final-year medical students
por: Mohigefer, Javier, et al.
Publicado: (2017)